Etomoxir - Docslib

Sign Up
Log In
Upload

Sign Up
Log In
Upload

Home
» Tags
» Etomoxir

Etomoxir

"This Is the Peer Reviewed Version of the Following Article: Murray, M., Dyari, H
2015 Annual Meeting Abstract Supplement Late-Breaking Abstract Submissions
Lipid Metabolic Reprogramming: Role in Melanoma Progression and Therapeutic Perspectives
Information to Users
Etomoxir, Sodium 2-[6-(4Chlorophenoxy)Hexyl]Oxirane-2-Carboxylate, Increases Uncoupling Protein-3 Mrna Levels in Primary Culture
Role of PPAR and Its Agonist in Renal Diseases
Targeting Fatty Acid Oxidation to Promote Anoikis and Inhibit Ovarian Cancer Progression 2 3 4 Brandon T
Targeting Ppars
Role of Pparα and Its Agonist in Renal Diseases
Novel Mechanisms of CNS Fuel Sensing
Peroxisome Proliferator-Activated Receptors (Ppars): Novel Therapeutic Targets in Renal Disease
Fatty Acid Signaling in the -Cell and Insulin Secretion
Functional Analysis of Molecular and Pharmacological Modulators of Mitochondrial Fatty Acid Oxidation
Diabetes and Obesity Research Tools
Merrill, Christine Lee
Fatty Acid Oxidation Makes the Difference: Lineage-Selective Disturbance by DEHP Via ROS in Myeloid Hematopoiesis
Lipid Metabolism and Cancer Immunotherapy: Immunosuppressive Myeloid Cells at the Crossroad
Fatty Acid Oxidation and Ketogenesis in Energy Homeostasis

Top View

Integrated Physiology/Obesity
Activation of Cannabinoid Receptors Prevents Endothelin-1-Induced Cardiac Myocyte Hypertrophy and Mitochondrial Dysfunction by Y
Mechanisms of Action of Rosiglitazone in the Protection of Pancreatic Beta Cells from Free Fatty Acid Induced Damage
Pettersen.Pdf (3.313Mb)
Upregulation of CPT1A Is Essential for the Tumor-Promoting Effect of Adipocytes in Colon Cancer
Adipose Tissue in Control of Metabolism
Fatty Liver Disease (Nafld/Nash)
1.7.2 Non-Antioxidant Functions of Vitamin E 50

© 2024 Docslib.org Feedback